Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dependence01:17

Drug Dependence

1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

334
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
334
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.1K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.5K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.6K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.3K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Togetherness in Couples Living With Chronic Obstructive Pulmonary Disease: An Interpretive Interview Study.

Journal of clinical nursing·2026
Same author

Translation of the Breathing Vigilance Questionnaire for respiratory diseases.

Danish medical journal·2026
Same author

Distribution of a novel DsrEFH sulfur transferase suggests widespread sulfur oxidation capacity in sulfate reducers.

The ISME journal·2026
Same author

National and Individual-Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations-A Nationwide Cohort Study.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Extracellular electron transfer in cable bacteria enables growth rates comparable to aerobic respiration.

Nature communications·2026
Same author

Long-term risk of depression in lung, colon, breast, and prostate cancer: a 25-year nationwide comparative study.

BMC cancer·2026

Related Experiment Video

Updated: Aug 29, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.5K

[Smoking cessation and drug interactions].

Helle Karkov Lindberg Madsen1, Mette Gulløv2, Ingeborg Farver-Vestergaard3

  • 1Farmakologi - Odense Universitetshospital.

Ugeskrift for Laeger
|September 6, 2022
PubMed
Summary
This summary is machine-generated.

Tobacco smoke significantly impacts drug metabolism, particularly for medications processed by CYP1A2. Smokers require higher drug doses, and quitting can lead to potentially harmful increases in medication levels, necessitating dose adjustments.

More Related Videos

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

876

Related Experiment Videos

Last Updated: Aug 29, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.5K
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

876

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Metabolism

Background:

  • Tobacco smoke contains compounds that induce the enzyme Cytochrome P450 1A2 (CYP1A2).
  • CYP1A2 is responsible for metabolizing several important medications, including clozapine, olanzapine, and theophylline.
  • This induction leads to altered drug efficacy and safety profiles in smokers.

Purpose of the Study:

  • To elucidate the pharmacokinetic interactions between tobacco smoke and CYP1A2-metabolized drugs.
  • To highlight the clinical implications of smoking cessation on drug plasma concentrations.
  • To inform appropriate medication management strategies for smokers and individuals undergoing smoking cessation.

Main Methods:

  • Review of existing literature on CYP1A2 enzyme activity and tobacco smoke.
  • Analysis of drug interaction studies involving smokers and non-smokers.
  • Examination of case reports and clinical guidelines related to smoking cessation and drug therapy.

Main Results:

  • Smokers exhibit significantly higher clearance of CYP1A2 substrates, requiring increased dosages for therapeutic effect.
  • Smoking cessation results in decreased CYP1A2 activity, potentially leading to supra-therapeutic drug levels and adverse events.
  • Bupropion is identified as a smoking cessation aid with clinically relevant drug interactions.

Conclusions:

  • Tobacco smoke-induced CYP1A2 activity necessitates dose adjustments for numerous medications in smokers.
  • Smoking cessation requires careful monitoring and potential dose reduction of CYP1A2 substrates to prevent toxicity.
  • Pharmacists and physicians must consider smoking status and cessation plans when prescribing and managing medications metabolized by CYP1A2.